U.S. Sexual Dysfunction Medication Markets

 


The U.S. Sexual Dysfunction Medication markets report provides revenue forecasts, patient forecasts, pricing forecasts, competitive analysis, market trends, and product analysis. The market is segmented into the male sexual dysfunction medication market and the female sexual dysfunction medication market. Within the male segment, subsegments analyzed in detail include the erectile dysfunction and hypogonadism medication markets addressing the various medication classes used to treat these conditions. Within the female segment, subsegments analyzed in detail include the hypoactive desire disorder and female sexual arousal disorder markets addressing the various medication classes used in treating these conditions.

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

Table of Contents

U.S. Sexual Dysfunction Medication Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Sexual Dysfunction Medication Markets, Total MarketOverviewIntroductionReport Scope and SegmentationCustomer Segmentation and Targeting StrategiesMarket DynamicsMarket Drivers (Male and Female Market Segments)Market Restraints (Male and female market segments)Challenge 1: Low Medication Compliance Limits Revenue PotentialChallenge 2: Restricted Product Differentiation Intensifies Competition and Diminishes Revenue PotentialChallenge 3: Growing Difficulty in Securing Reimbursement Curbs Revenue GrowthMarket Forecasts and TrendsDemand Analysis (Males and Females)Market TrendsRevenue ForecastCompetitive AnalysisCompetitive Structure and Strategic RelationshipsAuxilium PharmaceuticalsCellegy PharmaceuticalsEli Lilly/ICOSBioSante PharmaceuticalsMacroChem CorporationNexMed Inc.Product Life Cycle AnalysisProduct AnalysisApproved Products and Patent and Market Exclusivity ExpirationsFrost & Sullivan Technology Innovation AwardProduct Pipeline for the Total Sexual Dysfunction MarketU.S. Sexual Dysfunction Medication Markets, Male Sexual Dysfunction Medication MarketOverviewIntroduction Market Engineering AnalysisErectile Dysfunction MarketHypogonadal MarketForecastsPatient ForecastsPricing Analysis and ForecastsRevenue ForecastsU.S. Sexual Dysfunction Medication Markets, Female Sexual Dysfunction Medication MarketOverviewIntroductionHypoactive Desire Disorder MarketMarket Engineering AnalysisFemale Sexual Arousal Dysfunction MarketForecasts and TrendsPatient ForecastsPricing Analysis and ForecastRevenue ForecastsU.S. Sexual Dysfunction Medication Markets, AbstractsAbstractsHypertension Percent PrevalencePrevalence of DiabetesNumber of Urologists (World)Number of Obstetrics and Gynecologists (World)Number of General Practitioners (World)




Related Research

Release Date : 11-Aug-17

Region : North America

Release Date : 10-Aug-17

Region : North America

Release Date : 09-Aug-17

Region : North America

Release Date : 08-Aug-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.